BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 22713447)

  • 1. Successful treatment of pyoderma gangrenosum with intravenous immunoglobulins during pregnancy.
    Erfurt-Berge C; Herbst C; Schuler G; Bauerschmitz J
    J Cutan Med Surg; 2012; 16(3):205-7. PubMed ID: 22713447
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pyoderma gangrenosum in a pregnant patient: A case report and literature review.
    Takeshita N; Takashima A; Ishida H; Manrai M; Kinoshita T
    J Obstet Gynaecol Res; 2017 Apr; 43(4):775-778. PubMed ID: 28418207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutrophilic dermatoses: a review of current treatment options.
    Cohen PR
    Am J Clin Dermatol; 2009; 10(5):301-12. PubMed ID: 19658442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pyoderma gangrenosum stabilized with lymecycline, topical benzoyl peroxide and treated by autograft.
    Vereecken P; Wautrecht JC; De Dobbeleer G; Heenen M
    Dermatology; 1997; 195(1):50-1. PubMed ID: 9267739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The use of high-dose immunoglobulin in the treatment of pyoderma gangrenosum.
    Hagman JH; Carrozzo AM; Campione E; Romanelli P; Chimenti S
    J Dermatolog Treat; 2001 Mar; 12(1):19-22. PubMed ID: 12171682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyoderma gangrenosum at multiple sites in a post-colostomy ulcerative colitis patient with chronic hepatitis B virus: A case report.
    Wang B; Liu T; Liu F; He YL
    Int Wound J; 2020 Feb; 17(1):187-190. PubMed ID: 31663272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case of pyoderma gangrenosum responding to high-dose intravenous immunoglobulin therapy.
    Zhang XB; He YQ; Zhou H; Luo Q; Li CX
    Chin Med J (Engl); 2006 Jul; 119(14):1230-2. PubMed ID: 16863619
    [No Abstract]   [Full Text] [Related]  

  • 8. Pyoderma gangrenosum in a patient with essential thrombocythemia.
    King KW; Murray A
    J Cutan Med Surg; 2000 Apr; 4(2):107-9. PubMed ID: 11179935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pyoderma gangrenosum treated with high-dose intravenous immunoglobulins: Two cases and review of the literature.
    Meyer N; Ferraro V; Mignard MH; Adamski H; Chevrant-Breton J
    Clin Drug Investig; 2006; 26(9):541-6. PubMed ID: 17163287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Management of pyoderma gangrenosum. An update on clinical features, diagnosis and therapy].
    Trémezaygues L; Schmaltz R; Vogt T; Reichrath J
    Hautarzt; 2010 Apr; 61(4):345-53; quiz 354-5. PubMed ID: 20361320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucocutaneous pyoderma gangrenosum: a case report and literature review.
    Đorđević Betetto L; Točkova O; Bergant Suhodolčan A
    Acta Dermatovenerol Alp Pannonica Adriat; 2022 Mar; 31(Suppl):S10-S13. PubMed ID: 35339135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pyoderma Gangrenosum with Splenic Abscess- A Rare Association.
    Bansal A; Singla A; Singh A; Kaur S
    Indian Dermatol Online J; 2022; 13(2):244-247. PubMed ID: 35287426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel therapy for the treatment of pyoderma gangrenosum.
    Azizan NZ; Gangaram HB; Hussein SH
    Med J Malaysia; 2008 Mar; 63(1):51-4. PubMed ID: 18935734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum with pulmonary involvement?
    Liu ZH; Lu XL; Fu MH; Zhang GY; Liu WD
    Eur J Dermatol; 2008; 18(5):583-5. PubMed ID: 18693166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical factors influencing the response to intravenous immunoglobulin treatment in cases of treatment-resistant pyoderma gangrenosum.
    Haag CK; Ortega-Loayza AG; Latour E; Keller JJ; Fett NM
    J Dermatolog Treat; 2020 Nov; 31(7):723-726. PubMed ID: 30998080
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyoderma gangrenosum with pathergy in a pregnant patient without associated systemic disease.
    Reddy K; Brightman L; Venna S
    Cutis; 2008 Mar; 81(3):255-8. PubMed ID: 18441849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory pyoderma gangrenosum with intravenous immunoglobulin.
    de Zwaan SE; Iland HJ; Damian DL
    Australas J Dermatol; 2009 Feb; 50(1):56-9. PubMed ID: 19178495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum and high titer serum anti-CCP2 antibodies.
    Das SK; Banerjee N; Khaskil S; Mukherjee SS
    JNMA J Nepal Med Assoc; 2012; 52(185):36-9. PubMed ID: 23279772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Idiopathic Pyoderma Gangrenosum With Azathioprine As the Primary Adjunct in an Asian Man: A Case Report.
    Nazir A; Zafar A
    Cureus; 2022 May; 14(5):e25177. PubMed ID: 35746991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radiation therapy for recalcitrant pyoderma gangrenosum.
    Rumeileh IA; Furlan C; Minatel E; Mascarin M
    G Ital Dermatol Venereol; 2014 Feb; 149(1):145-8. PubMed ID: 24566575
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.